Join us for an exclusive interview featuring A/Prof Peter Foley. He is a distinguished leader in dermatology and has made remarkable contributions to dermatological research and patient care throughout his career.
As the Director of Research at the Skin Health Institute and the Head of Dermatology Research at St Vincent’s Hospital Melbourne, A/Prof Foley will be sharing his extensive insights and experience in a session that promises to be both engaging and informative. This is a unique opportunity to hear from a renowned expert in the field and to connect with fellow members of our community.
Our Partnership Manager, Carolyn Dimech, will conduct the interview, which will ensure a thought-provoking, engaging yet light-hearted discussion.
Date | Wednesday 30 October 2024
Time | 6.30pm – 8:30pm
Venue | Skin Health Institute, 80 Drummond Street, Carlton, VIC
Please RSVP via the form below by Wednesday 23 October.
SPEAKERS
Associate Professor Peter Foley is the Director of Research at the Skin Health Institute and the Head of Dermatology Research at St Vincent’s Hospital Melbourne. He currently holds the position of Associate Professor, Department of Medicine at The University of Melbourne. He is a Visiting Medical Officer to the Photobiology, Dermatology Biologics, and Dermatology Investigation clinics at St Vincent’s Hospital Melbourne and the Phototherapy, Atopic Dermatitis, and Psoriasis Advanced Targeted Therapies clinics at the Skin Health Institute.
He has been an investigator in over 160 clinical trials, including trials for dupilumab, tralokinumab, lebrikizumab, nemolizumab, amlitelimab, rocatinlimab, baricitinib, upadacitinib and abrocitinib in atopic dermatitis, and has over 160 published manuscripts.
A/Prof Foley is Australia’s only councillor on the International Psoriasis Council (IPC), is a founding member of the Australasian Psoriasis Collaboration, is co-convener of the Australasian Dermatology Registry, and is chair of the steering committee for the Pillars of Dermatology Practice Symposium. Additionally, he is a part of the 'treat to target project' in atopic dermatitis, and co-authored 'Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative', 'Atopic dermatitis in adults: An Australian management consensus, and Dupilumab-associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting'.
